1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The Small Business Innovation Research program is the largest source of early-stage technology funding in the United States. Since 1982, SBIR has channeled over $60 billion to small businesses building innovations that federal agencies need and markets reward. Eleven agencies participate, each funding technologies aligned with its own mission — from defense systems and biomedical devices to clean energy and agricultural technology.
Unlike venture capital, SBIR grants are non-dilutive. You keep your equity. You own the IP. And the federal government becomes your first customer, not your investor. For technology startups and R&D-driven small businesses, SBIR represents a unique path: prove your concept with government funding, then commercialize on your own terms.
After a five-month lapse when program authorization expired in September 2025, SBIR and STTR were reauthorized through 2031 with significant new provisions — including Strategic Breakthrough Awards up to $30 million and mandatory foreign risk screening. Agencies are now restarting solicitations, making this one of the most important windows for new applicants in years.
| Phase | Purpose | Award Range | Duration |
|---|---|---|---|
| Phase I | Feasibility & proof of concept | $50,000 – $275,000 | 6–12 months |
| Phase II | Full R&D & prototype development | $750,000 – $1.75M | 2 years |
| Phase III | Commercialization (no SBIR funding) | Follow-on contracts & private investment | Varies |
| Strategic Breakthrough | Post-Phase II acceleration (new in 2026) | Up to $30M | Up to 48 months |
For a detailed walkthrough of each phase, including budget templates and timeline planning, see our Phase I vs Phase II comparison.
| Agency | Annual SBIR Budget | Focus Areas |
|---|---|---|
| Department of Defense | $1.8B+ | Defense tech, cybersecurity, space, autonomous systems |
| NIH (HHS) | $1.2B+ | Biomedical devices, diagnostics, therapeutics, digital health |
| NSF | $250M+ | Deep tech, AI/ML, advanced manufacturing, materials |
| DOE | $350M+ | Clean energy, nuclear, grid modernization, climate tech |
| NASA | $200M+ | Space technology, Earth observation, propulsion, materials |
| USDA | $35M+ | Agricultural technology, food safety, rural development |
| EPA | $15M+ | Environmental monitoring, water treatment, remediation |
| DHS | $30M+ | Homeland security, border tech, first responder tools |
| Dept. of Education | $15M+ | EdTech, assessment tools, learning platforms |
| DOT | $10M+ | Transportation safety, infrastructure, autonomous vehicles |
| NOAA (DOC) | $10M+ | Ocean tech, weather forecasting, fisheries, satellites |
Each agency runs its own solicitation cycle with different topics, formats, and timelines. For agency-specific strategy, see our DoD SBIR guide and NIH SBIR Phase I guide.
For the full eligibility checklist including post-reauthorization changes, read our SBIR eligibility rules for 2026. First-time applicants should start with our complete SBIR application guide.
Browse the open SBIR and STTR opportunities below to find solicitations matching your technology. Each listing includes the funding agency, deadline, award amount, and eligibility details. When you find a match, Granted AI can help you draft your Phase I proposal section by section — from technical approach to commercialization plan — in days instead of months.
Explore our full library of SBIR resources: the SBIR beginner's guide, budget templates, success rates by agency, and commercialization plan examples.
Blueprint MedTech Translator (UG3/UH3) is a multi-institute NIH cooperative agreement that funds the translation of medical devices from early-stage concepts toward clinical application. Structured as a phased Exploratory/Developmental award, the program supports up to ,000 per year for qualifying projects. The UG3 phase funds initial exploratory and developmental work, with successful projects advancing to the UH3 phase for more intensive translational activity. The application deadline is May 28, 2026. This mechanism is intended for investigators pursuing novel medical device innovations with a clear path toward clinical use and commercial viability.
National Cyber Hubs is sponsored by European Commission — Digital Europe Programme. Expected Outcome: World-class National Cyber Hubs across the Union, supported by state-of-the-art technology, acting as clearing houses for detecting, gathering and storing data on cybersecurity threats, analysing this data, and sharing and reporting CTI, reviews and analyses, taking into account well-established standards for sharing and automation processes. Threat intelligence and situational awareness capabilities and capacity building supporting strengthened collaboration between cybersecurity actors, including private and public actors. Targeted training courses on the basis of the ECSF to improve the capacity of cyber security roles. • Applications for automated notification of private and public actors about compromised or insecure systems Objective: Where a Member State decides to participate in the European Cybersecurity Alert System, it shall designate or, where applicable, establish a National Cyber Hub, a single entity acting under the authority of the Member State. National Cyber Hubs have the capacity to act as a reference point and gateway to other public and private organisations at national level for collecting and analysing information on cyber threats and incidents and to contribute to a Cross-Border Cyber Hub. They are capable of detecting, aggregating, and analysing data and information relevant to cyber threats and incidents, such as cyber threat intelligence, by using in particular state-of-the-art technologies, and with the aim of preventing incidents. For the following programming cycle, the emphasis is on continuation of activities initiated during past years. The objective is to create or strengthen National Cyber Hubs, with state-of-the-art tools for monitoring, understanding and proactively managing cyber events, in close collaboration with relevant entities such as CSIRTs, ISACs, etc. They will also, where possible, benefit from information and feeds from other Cyber Hubs in their countries and use the aggregated data and analysis to deliver early warnings to targeted critical infrastructures on a need-to-know basis. National Cyber Hubs could also consider the possibility of monitoring undersea infrastructure, such as submarine cables. Scope: The aim is to build capacity for new or existing National Cyber Hubs, e.g. equipment, tools, data feeds, as well as costs related to data analysis, interconnection with Cross-Border Cyber Hubs, etc. This can include for example automation, analysis and correlation tools and data feeds covering Cyber Threat Intelligence (CTI) at various levels, ranging from field data to Security Information and Event Management (SIEM) data to higher level CTI. Automation is a key aspect in the efficient handling and processing of information. Where available, already established standards should be used, such as the Common Security Advisory Framework (CSAF) 1 , for security advisories or for collecting and processing cybersecurity-related messages (e.g. IntelMQ project 2 ). Applications developed by Cyber Hubs/SOCs should be compatible with European standardisation projects like the EU vulnerability database (EUVD). National Cyber Hubs should also leverage state-of-the-art technology such as artificial intelligence and dynamic learning of the threat landscape and context. This also includes the use of shared cybersecurity information, to the extent possible based on existing taxonomies and/or ontologies, and hardware to ensure the secure exchange and storage of information. The operations should be built upon live network data and other training data required in the initial phases. Where relevant, consideration should be given to SMEs as the ultimate recipients of cybersecurity operational information. A key element is the translation of advanced AI, data analytics and other relevant cybersecurity tools from research results to operational tools, and further testing and validating them in real conditions in combination with access to supercomputing facilities (e.g. to boost Programme areas: DIGITAL Keywords: Artificial intelligence, Capacity building, Cyber-physical systems, Cybersecurity, Cybersecurity Domains, Defence, Real time data analytics, TSI (Technical Specifications for Interoperability), National Cyber Hub, cyber threats detection, information sharing, preparedness and resilience of critical infrastructures, response to cyber threats, submarine cable security
AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program; Request for Information is sponsored by Food and Drug Administration (FDA). The Food and Drug Administration (FDA) is issuing this request for information to solicit input on a proposed pilot program to assess how artificial intelligence (AI)-enabled technologies can improve efficiency, speed, and quality of decision-making in early phase clinical trial…
226 matching grants · showing 30
Note: Each funding opportunity description is a synopsis of information in the Federal Register application notice. For specific information about eligibility, please see the official application notice. The official version of this document is the document published in the Federal Register. Free Internet access to the official edition of the Federal Register and the Code of Federal Regulations is available on GPO Access at: http://www.access.gpo.gov/nara/index.html. Please review the official application notice for pre-application and application requirements, application submission information, performance measures, priorities and program contact information. Purpose of Program: The purpose of this program is to stimulate technological innovation in the private sector, strengthen the role of small business in meeting Federal research or research and development (R/R&D) needs, increase the commercial application of the U.S. Department of Education (Department) supported research results, and improve the return on investment from federally funded research for economic and social benefits to the Nation. Catalog of Federal Domestic Assistance (CFDA) Number: 84.133S-1. If you choose to submit your application electronically, you must use the Governmentwide Grants.gov Apply site at http://www.Grants.gov. Through this site, you will be able to download a copy of the application package, complete it offline, and then upload and submit your application. You may not e-mail an electronic copy of a grant application to us. You may access the electronic grant application for the SBIR Program at: http://www.Grants.gov. You must search for the downloadable application package for this competition by the CFDA number. Do not include the CFDA number's alpha suffix in your search (e.g. , search for 84.133, not 84.133S). The telephone number for the Grants.gov Helpdesk is 1-800-518-4726 or e-mail: support@grants.gov. Funding Opportunity Number: ED-GRANTS-090908-001. Assistance Listing: 84.133. Funding Instrument: G. Category: ED. Award Amount: Up to $75K per award.
Purpose. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, enhance and validate translational tools to facilitate rigorous study of complementary and alternative medicine (CAM) approaches that are in wide use by the public. Recent data from the National Health Interview Survey [http://www.cdc.gov/nchs/nhis.htm] establish that Americans are utilizing CAM approaches to promote health and well-being, to treat or prevent disease, and for symptom relief. CAM approaches being widely used include massage and manipulative therapies, meditation, yoga, and acupuncture. Health conditions, particularly chronic pain, back pain and musculoskeletal pain, are the most commonly cited reasons for their use. This FOA focuses on encouraging the development of improved tools to study safety, efficacy, and clinical effectiveness of widely used CAM approaches, such as: mind-body interventions, manual therapies, yoga, and acupuncture. This FOA is not focused on tools for the study of natural products, such as herbal therapies. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, RFA-AT-09-002, which solicits applications under the R01 grant mechanism. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 5 projects awarded as a result of this announcement is $1.25 million for fiscal year 2010. Future year amounts will depend on annual appropriations. Funding Opportunity Number: RFA-AT-09-004. Assistance Listing: 93.213. Funding Instrument: G. Category: HL. Award Amount: $1.3M total program funding.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
-This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for the modification or development of new screening technologies that are better able to consistently detect mild hearing loss (i.e., less than 40 dB Hearing Level or 40 dB HL) in one or both ears in infants and young children without significantly increasing the number of false positives (i.e., those who fail the screen but do not have hearing loss). -The Early Hearing Detection and Intervention (EHDI) program within the National Center for Birth Defects and Developmental Disabilities (NCBDDD) of the Centers for Disease Control and Prevention (CDC) and the National Institute on Deafness and Other Communication Disorders (NIDCD), NIH, are working to ensure infants and children with mild forms of hearing loss are identified as soon as possible. Part of this effort involves having screening technology available that can reliably detect these hearing losses. -This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-06-547, that solicits applications under the Small Business Technology Transfer (STTR [R41/R42]) grant mechanisms. Note,that CDC does not accept STTR applications so is participating only in PA-06-546. Funding Opportunity Number: PA-06-546. Assistance Listing: 93.173,93.283. Funding Instrument: G. Category: HL.
Purpose. This funding opportunity announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications that propose to develop novel pharmacologic agents for brain research related to mental disorders, including research aimed at discovering new drugs for these disorders. In addition, this FOA solicits SBIR grant applications that propose to take existing, promising compounds through the next step of drug discovery and development. Finally, this FOA also encourages SBIR grant applications designed to study the effectiveness of novel interventions. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Budget and Project Period. Phase I awards normally may not exceed $100,000 total for a period normally not to exceed 6 months. Phase II awards normally may not exceed $750,000 total for a period normally not to exceed 2 years. However, for this funding opportunity, budgets up to $350,000 total costs per year and time periods up to two years for Phase I may be requested. Budgets up to $600,000 total costs per year and up to three years may be requested for Phase II. Eligible Institutions/Organizations: Only United States SBCs are eligible to receive SBIR applications. A SBC is one that, on the date of award for both Phase I and Phase II funding agreements, meets ALL of the criteria as described in Section III. Eligible Project Directors/Principal Investigators: Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. On an SBIR application, the PD/PI must have his/her primary employment (more than 50%) with the SBC at the time of award and for the duration of the project. Number of Applications: Applicant SBCs may submit more than one application, provided each application is scientifically distinct. Resubmissions: Applicants may submit a resubmission application, but such application must include an Introduction addressing the previous peer review critique (Summary Statement). Number of PDs/PIs. More than one PD/PI, or multiple PDs/PIs, may be designated on the application. Funding Opportunity Number: PA-08-142. Assistance Listing: 93.242. Funding Instrument: G. Category: HL.
This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose the development and translation of technologies to improve hearing healthcare outcomes. Responsive applications must seek to increase utilization of hearing health care technology by underserved patients and thus reduce health disparities. Funding Opportunity Number: RFA-DC-12-001. Assistance Listing: 93.173. Funding Instrument: G. Category: HL. Award Amount: Up to $150K per award.
The United States Agency for International Development (USAID)s Bureau for Food Security (BFS) under the management of the Office of Country Strategy and Implementation Support (CSI) is continuing USAIDs long-term support for the Farmer-to-Farmer (F2F) Program. This RFA is issued to solicit applications to manage F2F volunteer programs under Leader with Associate Cooperative Agreements (LWAs). The LWAs resulting from this RFA will enable USAID to continue its support for US voluntary assistance for economic growth in the agricultural sector at regional and country levels. The LWA mechanism will facilitate USAID Mission funding to expand volunteer assistance and impact on agricultural program element objectives.Issuance of this RFA does not constitute an award commitment on the part of the Government, nor does it commit the Government to pay for costs incurred in the preparation and/or submission of an application. Applicants who come under consideration for an award that have never received USAID funding will be subject to a pre-award audit to determine fiscal responsibility, ensure adequacy of financial controls, and establish an indirect cost rate (if applicable). For the purposes of this RFA, the term Grant is synonymous with Cooperative Agreement; "Grantee" is synonymous with "Recipient;" and "Grant Officer" is synonymous with "Agreement Officer". The authority for this RFA is found in the Foreign Assistance Act of 1961, as amended. USAID intends to award up to eight (8) Leader with Associate Awards in the form of Cooperative Agreements with each base program in the amount of $8 Million subject to the availability of funds. Each Leader Award will have a period of performance of up to five (5) years. Applicants may propose implementation periods of less than five (5) years (cost efficiencies and project effectiveness should be considered) but no more than five (5) years. Additional associate award(s) may be placed at a future time under a separate RFA process. Projects proposed with an implementation period of more than five (5) years will not be considered. Competition under this RFA will be conducted in two phases: Phase I: Concept Note Phase II: Full ApplicationEach applicant shall initially provide USAID with a Concept Note. The Concept Note shall be competitively evaluated against the pre-determined evaluation criterion. The most highly technically qualified Concept Notes will be invited to submit Part II Full Application under this RFA. Unsuccessful applicants will be notified in a timely manner and provided written feedback. Funding Opportunity Number: SOL-OAA-13-00006. Assistance Listing: 98.009. Funding Instrument: CA. Category: AG. Award Amount: Up to $8M per award.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating components invite grant applications for research on the development of safe, real-time, non-invasive (or minimally invasive), in vivo methods to assess the development and function of the human placenta. Funding Opportunity Number: RFA-HD-14-005. Assistance Listing: 93.286,93.865. Funding Instrument: G. Category: HL,ISS.
NIST invites applications for a program involving technical and business engagement activities directed at small businesses participating in NISTs Small Business Innovation Research Program. The TCAP recipient will provide NIST SBIR Phase I and/or Phase II recipients with technical and business expertise and resources to identify optimum pathways to promote successful transition of the Phase I and/or Phase II results to commercialization. Funding Opportunity Number: 2014-NIST-SBIR-02. Assistance Listing: 11.620. Funding Instrument: CA. Category: ST.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
This initiative will stimulate and support innovative research by small business concerns that may lead to the development of novel technologies for the early diagnosis, monitoring and treatment of micro and macro vascular complications of diabetes which are associated with significant morbidity and mortality of the disease and high costs to the health care system. Funding Opportunity Number: PA-14-058. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL.
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications that propose to continue the process of developing complex instrumentation, clinical research tools, or behavioral interventions and mental disorders. This FOA specifically invites applications for the competing renewal of previously funded Phase II SBIR grants to further develop the aforementioned types of technologies. Funding Opportunity Number: PA-14-219. Assistance Listing: 93.242. Funding Instrument: G. Category: HL. Award Amount: Up to $800K per award.
Since its inception in 1953, SBA has served to aid, counsel, assist and protect the interests of small businesses. While SBA is best known for its financial support of small businesses through its many lending programs, the Agency also plays a critical role in providing funding to organizations that deliver technical assistance in the form of counseling and training to small business concerns and nascent entrepreneurs in order to promote growth, expansion, innovation, increased productivity and management improvement. The mission of SBA’s Office of Innovation & Technology, which bears responsibility for administering the FAST Program, is to strengthen the technological competitiveness of small businesses across the country through coordination of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The FAST program focuses on increasing the participation of small firms in the innovation and commercialization of high risk technologies, keeping the United States on the cutting edge of next generation research and development. The Federal and State Technology (FAST) Partnership Program provides one year funding to organizations to execute state/regional programs that increase the number of SBIR/STTR proposals (through outreach and financial support); increase the number of SBIR/STTR awards (through technical assistance and mentoring); and better prepare SBIR/STTR awardees for commercialization success (through technical assistance and mentoring). Funding Opportunity Number: FAST-2018-R-0012A. Assistance Listing: 59.058. Funding Instrument: G. Category: BC,ST. Award Amount: $50K – $125K per award.
This NOFO provides an opportunity to all FY 2018 NIST SBIR Phase I awardees to submit a Phase II application following completion of Phase I. This NOFO provides instructions for FY 2019 NIST SBIR Phase II application preparation and submission requirements. In Phase II, work from Phase I that exhibits potential for commercial application is further developed. Phase II is the R&D or prototype development phase. To apply for a Phase II award, each Phase I awardee will be required to submit a comprehensive application outlining the proposed research and a detailed plan to commercialize the final product. Each NIST Phase II award is for up to $400,000 and up to a 24-month period of performance. One year after completing the Phase II R&D activity, the awardee shall be required to report on its commercialization activities. Up to an additional $6,500 may be requested for Technical and Business Assistance (TABA); see Section 5.11 for more information about TABA. Funding Opportunity Number: 2019-NIST-SBIR-02. Assistance Listing: 11.620. Funding Instrument: CA. Category: ST. Award Amount: Up to $400K per award.
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The FOA aims to facilitate the transition of previously funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance not typically supported through Phase II or Phase IIB grants or contracts. This may include preparation of documents for a Food and Drug Administration (FDA) submission, development of an intellectual property strategy, and/or planning for a clinical trial. Although a significant amount of the work in a CRP award may be subcontracted to other organizations, the SBC is expected to maintain oversight and management of the R and D throughout the award. Clinical trials not accepted under this FOA. Funding Opportunity Number: PAR-19-334. Assistance Listing: 93.113,93.121,93.172,93.173,93.233,93.242,93.273,93.286,93.350,93.393,93.394,93.395,93.396,93.399,93.837,93.838,93.839,93.840,93.846,93.847,93.855,93.859,93.866,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
All Phase II projects must have previously completed a successful USDA Phase I project before applying for a Phase II grant. Success rates for applicants have been 50-60% for Phase II. Projects dealing with agriculturally-related manufacturing and alternative and renewable energy technologies are encouraged across all 2018 SBIR topic areas. USDA SBIR's flexible research areas ensure innovative projects consistent with USDA's vision of a healthy and productive nation in harmony with the land, air, and water. USDA SBIR has awarded over 2000 research and development projects since 1983, allowing hundreds of small businesses to explore their technological potential and providing an incentive to profit from the commercialization of innovative ideas. Click below for more SBIR information. Funding Opportunity Number: USDA-NIFA-SBIR-008080. Assistance Listing: 10.212. Funding Instrument: G. Category: AG. Award Amount: Up to $650K per award.
The purpose of this FOA is to provide funding for up to two (2) private, non-profit organizations that will provide entrepreneurial development services to women, with an emphasis on socially and economically disadvantaged entrepreneurs in locations that are outside of the geographical areas of existing WBCs for the District of Columbia (DC) and the State of Oregon. There will be one award for each location. Eligible applicants must be private, non-profit organizations with 501(c) tax exempt status from the U.S. Treasury’s Internal Revenue Service and must provide services to the District of Columbia (DC) and State of Oregon. Funding Opportunity Number: SB-OEDWB-23-002. Assistance Listing: 59.043. Funding Instrument: G. Category: BC,CD,RD. Award Amount: $75K – $150K per award.
The National Leadership Grants for Libraries Program (NLG-L) supports projects that address critical needs of the library and archives fields and have the potential to advance practice and strengthen library and archival services for the American public. Successful proposals will generate results such as new models, tools, research findings, services, practices, and/or alliances that can be widely used, adapted, scaled, or replicated to extend and leverage the benefits of federal investment. Applications to IMLS should both advance knowledge and understanding and ensure that the federal investment made generates benefits to society. Specifically, the goals for this program are to generate projects of far-reaching impact that: • Build the workforce and institutional capacity for managing the national information infrastructure and serving the information and education needs of the public. • Build the capacity of libraries and archives to lead and contribute to efforts that improve community well-being and strengthen civic engagement. • Improve the ability of libraries and archives to provide broad access to and use of information and collections with emphasis on collaboration to avoid duplication and maximize reach. • Strengthen the ability of libraries to provide services to affected communities in the event of an emergency or disaster. • Strengthen the ability of libraries, archives, and museums to work collaboratively for the benefit of the communities they serve. Throughout its work, IMLS places importance on diversity, equity, and inclusion. This may be reflected in an IMLS-funded project in a wide range of ways, including efforts to serve individuals of diverse geographic, cultural, and socioeconomic backgrounds; individuals with disabilities; individuals with limited functional literacy or information skills; individuals having difficulty using a library or museum; and underserved urban and rural communities, including children from families with incomes below the poverty line. Application Process: The application process for the NLG-L program has two phases; applicants must begin by applying for Phase I. For Phase I, all applicants must submit Preliminary Proposals by the September 20th deadline listed for this Notice of Funding Opportunity. For Phase II, only selected applicants will be invited to submit Full Proposals, and only those Invited Full Proposals will be considered for funding. Invited Full Proposals will be due March 20, 2024. Funding Opportunity Number: NLG-LIBRARIES-FY24. Assistance Listing: 45.312. Funding Instrument: G. Category: AR,HU. Award Amount: $50K – $1M per award.
The Small Business Innovation Research (SBIR) Program for CHIPS for America – CHIPS Metrology seeks applications from eligible applicants to explore the technical merit or feasibility of an innovative idea or technology with the aim of developing a viable product or service that will be introduced to the commercial microelectronics marketplace. This NOFO contains multiple topics on research projects for critically needed measurement services, tools, and instrumentation; innovative manufacturing metrologies; novel assurance and provenance technologies and advanced metrology research and development (R&D) testbeds to help secure U.S. leadership in the global semiconductor industry. Funding Opportunity Number: 2024-SBIR-CHIPS-01. Assistance Listing: 11.042,11.620. Funding Instrument: CA. Category: ST.
Small Business Innovation Research (SBIR) Program Phase I is sponsored by U.S. Environmental Protection Agency (EPA). The EPA SBIR Phase I Solicitation invites small businesses to submit proposals for projects addressing critical environmental challenges. Awards are for six months to demonstrate proof of concept. Key focus areas include Clean and Safe Water, Air Quality and Climate, Homeland Security, Circular Economy/Sustainable Materials, and Safer Chemicals.
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs is sponsored by Environmental Protection Agency (EPA). The EPA SBIR program supports the development and commercialization of innovative environmental technologies that address the Agency's mission. This includes projects focused on climate change solutions, air quality, circular economy/sustainable materials, and other environmental threats.
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs Phase I (FY 2025) is sponsored by U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA). The USDA SBIR/STTR programs focus on transforming scientific discovery into products and services with commercial potential and/or societal benefit. Projects dealing with agriculturally-related manufacturing and alternative and renewable energy technologies are encouraged across all SBIR/STTR topic areas.
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs (USDA NIFA) is sponsored by U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA). The USDA SBIR/STTR programs offer grants for small businesses to conduct high-quality research related to important scientific problems and opportunities in agriculture, with an emphasis on transforming scientific discovery into commercial products and services. This includes advanced technologies and software solutions relevant to agriculture. The FY 2025 Phase I funding opportunity has a closing date of September 17, 2024.
Small Business Innovation Research - Food Science and Nutrition (SBIR 8.5) is sponsored by USDA National Institute of Food and Agriculture (NIFA). This program supports innovations in food manufacturing technologies and strengthening agricultural systems. It focuses on improving production, storage, and quality of foods through research, education, and extension. Projects can address emerging food safety, food processing, and nutrition issues, including developing systems for rapid detection of pathogens and chemical hazards, and technologies for climate-smart food systems. The outcome of a successful project is a proof of concept for a marketable product or patented process.
Small Business Innovation Research (SBIR) / Small Business Technology Transfer (STTR) Programs (Phase I) is sponsored by U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA). The USDA SBIR/STTR programs focus on transforming scientific discovery into products and services with commercial potential and/or societal benefit in agriculturally-related areas. This can include app development for agricultural technology, rural development, and smart farming. Phase I aims to demonstrate technical feasibility.
Small Business Innovation Research (SBIR) Program is sponsored by NOAA. This program provides seed funding to small businesses for research and development of innovative technologies across NOAA's mission areas, including climate change adaptation and mitigation, coastal resilience, and extreme weather events. Phase I awards fund a six-month period for conducting feasibility and proof of concept research.
NOAA Small Business Innovation Research (SBIR) Program FY 2025 Phase I is sponsored by National Oceanic and Atmospheric Administration (NOAA). The NOAA SBIR Program encourages proposals from qualified small businesses for highly innovative technologies with strong commercial potential that fit within NOAA's mission areas, including Artificial Intelligence. Phase I awards fund a six-month period for feasibility and proof of concept research.
Small Business Innovation Research Program (SBIR) Phase II is sponsored by Administration for Community Living. Small Business Innovation Research Program (SBIR) Phase II is a forecasted funding opportunity on Grants.gov from Administration for Community Living. Fiscal Year: 2026. Assistance Listing Number(s): 93.433. <p>The purpose of the Federal SBIR program is to stimulate technological innovation in the private sector, strengthen the role of small business in meeting Federal research or research and development (R/R&D) needs, and improve the return on investment from Federally-funded research for economic and social benefits to the nation. The specific purpose of NIDILRR's SBIR program is to improve the lives of people with disabilities through R/R&D products generated by small businesses, and to ...
EPA Small Business Innovation Research Phase I is sponsored by Environmental Protection Agency (EPA). The EPA SBIR program funds small businesses developing innovative environmental technologies with commercial potential. It supports research into solutions addressing pollution, circular economy challenges, PFAS destruction, and other environmental priorities. Successful Phase I companies may progress to Phase II for further development.
Use our free grant finder to search active federal funding opportunities by agency, eligibility, and deadline.
Get a free Grant Score and see how well your organization matches grants like this one.
NASA selected 15 small businesses for SBIR Ignite Phase I awards on April 14 in AI, robotics, and radar. The $150K Phase I gates a $1.275M Phase II — and the commercialization-first framing is reshaping who should apply where.
Read articleS. 3971 — the Small Business Innovation and Economic Security Act — reauthorized SBIR and STTR through September 30, 2031 after a six-month lapse. The legislation adds Strategic Breakthrough Awards up to $30M with 100% matching, eight-watchlist foreign-affiliation screening, and FY 2027 per-company proposal caps. Companies that built their pipeline around volume submissions need a new strategy now.
Read articleNASA's SBIR/STTR Program Year 2026 abandons the annual solicitation in favor of a rolling BAA. Phase I awards jump to \$225K and Phase II to \$1.275M. Here is the playbook.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn April 13, 2026, President signed S. 3971 reauthorizing SBIR/STTR through September 30, 2031 — the longest extension in program history. The new law introduces $30M Strategic Breakthrough Awards, FY2027 proposal caps to address SBIR mills, expanded foreign-risk screening, and stronger TABA support. Here is how small businesses, university spinouts, and dual-use startups should reposition for the next two solicitation cycles.
Read articleNASA released a Broad Agency Announcement on April 17, 2026, that replaces the agency's traditional annual SBIR/STTR solicitation cycle with a phased-appendix model valid through September 30, 2027. Appendix A and Appendix B opened April 21 with a May 21 deadline; additional appendices will release throughout the BAA period. The shift breaks the once-a-year proposal cadence small businesses have planned around since the program's founding and demands a different operational posture.
Read article